Renovo renovo.com


Public lists: Pharma Startups (4732)

Renovo provides drug discovery and development for scar prevention and reduction.

Renovo provides drug discovery and development for scar prevention and reduction.

Company (Alive / Active)

Phone:

Fax:

The Manchester Incubator Building
48 Grafton Street
M13 9XX
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Renovo $0M Nov 21, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Renovo Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Cardiac Pathways

Sunnyvale, California, United States
AcquiredCardiac Pathways manufactures minimally invasive systems used by electrophysiologists to diagnose and treat cardiac tachyarrhythmias, which if untreated can cause palpitations, fainting, and sudden cardiac arrest. Cardiac Pathways' products consist principally of systems for performing ablation treatment and for diagnostic mapping.Login to see details

Radius Health

Waltham, Massachusetts, United States
IPO / Went publicRadius Health is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions. Radius is committed to the development of advanced therapeutics for the large and underserved osteoporosis market. The company's lead product candidate, BA058-SC, is in development to reduce the risk of complications associated with osteoporosis, such as fracture. The company also has a next-generation transdermal patch, BA058-TD, being develo...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Tgf-β3 mutants Mar 12, 2007 May 24, 2011 Patent
Medicaments and proteins based on tgf-β monomers for the treatment of wounds Mar 12, 2007 Mar 08, 2011 Patent
Protein folding Mar 09, 2007 Feb 22, 2011 Patent
Method of promoting the healing of a chronic wound Jul 05, 2007 Jun 01, 2010 Patent
Pharmaceutical composition containing an activin or inhibin stimulator Sep 05, 2003 May 11, 2010 Patent
See all 8 patents